Abbott Laboratories (ABT) Q3 2022 Earnings Results

Abbott Laboratories Beats on EPS, Stock Down 6.54%

Abbott Laboratories reported a strong EPS that exceeded expectations, but the stock fell by 6.54% in reaction. This decline may reflect investor concerns or broader market trends, as no revenue figures or guidance were provided to clarify future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.15	N/A	+26.93%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record for the earnings call, so the analysis is based solely on numerical results.

Abbott Laboratories Beats on EPS, Stock Down 6.54%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Laboratories Beats on EPS, Stock Down 6.54%

Key numbers

Management commentary